ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment Tags GLP-1 agonists Read more about ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment
ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass Tags GLP-1 agonists Read more about ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass
ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity Tags GLP-1 agonists Read more about ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity
ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss Tags GLP-1 agonists Read more about ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss
ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch Tags GLP-1 agonists Read more about ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch
ECO 2026: EASO Updates Obesity Drug Guidance Algorithm Tags GLP-1 agonists Read more about ECO 2026: EASO Updates Obesity Drug Guidance Algorithm
Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis Tags GLP-1 agonists Read more about Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis
Sex Differences in Metabolic Profile Observed in Prepubertal Obesity Read more about Sex Differences in Metabolic Profile Observed in Prepubertal Obesity
Weight-Loss Efforts Declined 3 to 6 Years After T2DM Diagnosis Read more about Weight-Loss Efforts Declined 3 to 6 Years After T2DM Diagnosis
Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM Tags GLP-1 agonists Read more about Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM